G. L. Odierna and W. Phillips, “Targeting the safety factor for neuromuscular transmission to treat myasthenia gravis: Safety factor for neuromuscular transmission”, rrnmf, vol. 4, no. 3, Aug. 2023, doi: 10.17161/rrnmf.v4i3.19543.